Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: PEG-MGF + MGF + IGF-1 LR3 evidence and
This entry is a multi-compound blend. Each component can be opened individually in the reconstitution calculator.
Component amounts shown are arithmetic starters based on equal distribution. Edit values in the calculator before saving.
PEG-MGF + MGF + IGF-1 LR3 combines PEG-MGF + MGF + IGF-1 LR3 into a single research protocol. Each component is independently studied; this entry summarizes the individual evidence base for the combination, since no unified safety/efficacy dataset covers the mixed formulation unless noted below. PEG-MGF: PEGylated form of the MGF E-domain peptide; PEG conjugation extends half-life from minutes to approximately 24 hours, activating the satellite-cell proliferation phase of muscle repair. MGF: Splice variant of IGF-1 (IGF-1Ec) produced locally by skeletal muscle in response to mechanical loading/damage; activates satellite cells as an early step in muscle repair/hypertrophy. IGF-1 LR3: Long-acting IGF-1 analog (Arg3, extended N-terminus) with reduced IGFBP binding, providing robust and prolonged IGF-1 receptor pathway activation for the differentiation/protein-synthesis phase of muscle growth. This is a community-stacking combination assembled from two independently studied compounds rather than a pharmaceutical sponsor's dedicated fixed-dose combination program - no dedicated human combination trial exists for this exact pairing as of this writing.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Evidence for individual components does not validate the exact mixed formulation. Component amounts, ratios, compatibility, sterility, and stability must be documented.
Supplementary research context only. Not medical advice or a treatment recommendation.
Best-effort summary of forum/Reddit discussion. This is anecdotal community commentary, not a scientific source, and does not count toward this record's verification status. Do not treat it as established fact or medical guidance.
Community protocols pairing PEG-MGF with IGF-1 LR3 (and sometimes unmodified MGF) are commonly discussed in bodybuilding-research circles for combined localized and systemic growth-factor signaling; reported effects are self-described and vary by user. Anecdotal, not clinically verified.
User shares a first-hand trial report of PEG-MGF, describing subjective muscle-recovery/growth effects; single self-reported account, not corroborated by clinical data.
Community protocol/discussion thread combining IGF-1 LR3 with PEG-MGF for localized/systemic growth-factor research use; discussion-oriented, largely anecdotal.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.